Simplex Trading
JNCE

Simplex Trading’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Simplex Trading’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,000
Closed -$9K – 10412
2023
Q1 		$9K Buy
+5,000
New +$6.19K ﹤0.01% 7683
2022
Q2 		– Sell
-13,100
Closed -$88K – 11534
2022
Q1 		$88K Buy
+13,100
New +$93.4K ﹤0.01% 6338
2021
Q1 		– Sell
-86
Closed -$60K – 10386
2020
Q4 		$60K Buy
86
+58
+207% +$451 ﹤0.01% 5995
2020
Q3 		$22K Buy
28
+13
+87% +$81 ﹤0.01% 6315
2020
Q2 		$10K Sell
15
-18
-55% -$97 ﹤0.01% 6677
2020
Q1 		$15K Sell
33
-177
-84% -$1.02K ﹤0.01% 6201
2019
Q4 		$183K Buy
+210
New +$1.14K ﹤0.01% 3873
2018
Q4 		– Sell
-10
Closed -$6K – 8067
2018
Q3 		$6K Sell
10
-46
-82% -$342 ﹤0.01% 6716
2018
Q2 		$42K Sell
56
-44
-44% -$635 ﹤0.01% 5244
2018
Q1 		$67K Buy
100
+91
+1,011% +$2.02K ﹤0.01% 2138
2017
Q4 		$2K Buy
+9
New +$132 ﹤0.01% 5307

Other funds holding JNCE

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Simplex Trading's JNCE Position: Q2 2023 in Review

Simplex Trading sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2023, closing a stake of 3,373 shares — an estimated $6K sold.

Simplex Trading first reported a position in JNCE in Q4 2017 and held it in 13 quarters. The position peaked at $354K in Q3 2018. 1 fund tracked by Wall St. Rank holds JNCE as of Q2 2023.

  • Simplex Trading reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 3,373 Jounce Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $6K.
  • Simplex Trading first reported a position in Jounce Therapeutics, Inc. Common Stock in Q4 2017 and held it in 13 quarters.
  • Simplex Trading's Jounce Therapeutics, Inc. Common Stock position peaked at $354K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.